Pacific Biosciences of California Inc (PACB)
1.38
+0.02
(+1.47%)
USD |
NASDAQ |
Apr 25, 16:00
1.40
+0.02
(+1.45%)
After-Hours: 20:00
Pacific Biosciences of California Price to Book Value: 0.5273 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 0.5273 |
| April 24, 2024 | 0.5196 |
| April 23, 2024 | 0.5617 |
| April 22, 2024 | 0.596 |
| April 19, 2024 | 0.5922 |
| April 18, 2024 | 0.5578 |
| April 17, 2024 | 0.5349 |
| April 16, 2024 | 0.5349 |
| April 15, 2024 | 1.083 |
| April 12, 2024 | 1.211 |
| April 11, 2024 | 1.291 |
| April 10, 2024 | 1.272 |
| April 09, 2024 | 1.379 |
| April 08, 2024 | 1.318 |
| April 05, 2024 | 1.28 |
| April 04, 2024 | 1.272 |
| April 03, 2024 | 1.284 |
| April 02, 2024 | 1.303 |
| April 01, 2024 | 1.395 |
| March 28, 2024 | 1.433 |
| March 27, 2024 | 1.421 |
| March 26, 2024 | 1.345 |
| March 25, 2024 | 1.379 |
| March 22, 2024 | 1.406 |
| March 21, 2024 | 1.467 |
| Date | Value |
|---|---|
| March 20, 2024 | 1.460 |
| March 19, 2024 | 1.391 |
| March 18, 2024 | 1.402 |
| March 15, 2024 | 1.448 |
| March 14, 2024 | 1.494 |
| March 13, 2024 | 1.62 |
| March 12, 2024 | 1.532 |
| March 11, 2024 | 1.681 |
| March 08, 2024 | 1.693 |
| March 07, 2024 | 1.754 |
| March 06, 2024 | 1.595 |
| March 05, 2024 | 1.662 |
| March 04, 2024 | 1.864 |
| March 01, 2024 | 1.983 |
| February 29, 2024 | 2.113 |
| February 28, 2024 | 2.128 |
| February 27, 2024 | 2.147 |
| February 26, 2024 | 1.998 |
| February 23, 2024 | 1.952 |
| February 22, 2024 | 1.960 |
| February 21, 2024 | 1.941 |
| February 20, 2024 | 2.021 |
| February 16, 2024 | 2.193 |
| February 15, 2024 | 2.548 |
| February 14, 2024 | 2.484 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5196
Minimum
Apr 24 2024
41.85
Maximum
Sep 29 2020
10.04
Average
6.760
Median
Oct 26 2021
Price to Book Value Benchmarks
| Cerus Corp | 5.853 |
| Axogen Inc | 2.945 |
| AVITA Medical Inc | 4.349 |
| BioSig Technologies Inc | -- |
| Intellia Therapeutics Inc | 1.832 |
Price to Book Value Related Metrics
| PS Ratio | 1.745 |
| Price | 1.38 |
| Earnings Yield | -87.68% |
| Market Cap | 369.77M |